Skip to content
Inciteful Med

The Biology of ADOA: Energy and the OPA1 Gene

Last updated:

Autosomal Dominant Optic Atrophy (ADOA) is typically caused by OPA1 gene mutations that damage cellular mitochondria. This creates a severe energy shortage that specifically targets the highly energy-dependent cells of the optic nerve, causing vision loss.

Key Takeaways

  • • The OPA1 gene produces a vital protein that helps your cellular mitochondria generate energy efficiently.
  • • Most ADOA patients produce only half the necessary OPA1 protein, a state known as haploinsufficiency.
  • • The shortage of OPA1 protein causes mitochondria to fragment, leading to a cellular energy deficit and harmful oxidative stress.
  • • Retinal Ganglion Cells (RGCs) in the optic nerve require massive amounts of energy, making them highly vulnerable to this mitochondrial failure.
  • • Unlike LHON, ADOA is caused by a nuclear DNA mutation and can be inherited from either parent.

To understand Autosomal Dominant Optic Atrophy (ADOA), it helps to look deep inside your cells at the tiny structures that keep them alive. While we often think of vision as a simple biological process, it is actually one of the most energy-intensive tasks your body performs.

The OPA1 Gene: The Master Architect

Your body contains a gene called OPA1, located in your nuclear DNA (the “instruction manual” found in the center of almost every cell) [1]. This gene provides the instructions for making the OPA1 protein.

The OPA1 protein lives inside the mitochondria, the “powerhouses” of your cells [2]. Its job is to act as an architect and maintenance worker. It oversees two critical tasks:

  1. Mitochondrial Fusion: This is the process where two mitochondria merge into one. This allows them to share resources and repair damaged parts [3][4].
  2. Cristae Maintenance: Inside every mitochondrion are tiny folds called cristae. These folds are where energy (ATP) is actually produced. OPA1 keeps these folds tight and organized so the cell can generate power efficiently [3][5].

What Happens in ADOA?

In most people with ADOA, the OPA1 mutation causes a situation called haploinsufficiency [6][7]. This means that because one copy of the gene is “broken,” the body only produces about half the amount of OPA1 protein it needs.

Without enough OPA1, the architecture of the mitochondria begins to fail:

  • Fragmentation: Instead of long, healthy networks, the mitochondria break apart into small, weak pieces [8][9].
  • Energy Deficit: The disorganized cristae cannot produce enough ATP energy, leading to a “cellular energy shortage” [10][11].
  • Oxidative Stress: Struggling mitochondria leak harmful molecules called Reactive Oxygen Species (ROS), which act like “cellular rust,” damaging the cell from the inside out [12][13].

Why the Optic Nerve?

You might wonder why a problem affecting all your cells primarily impacts your vision. The answer lies in the Retinal Ganglion Cells (RGCs). These are the long, thin cells that make up your optic nerve [11].

RGCs are unique because they have very long axons (nerve fibers) that require a massive, constant supply of energy to send visual signals to the brain [10][14]. When the OPA1 protein is low, these cells are the first to suffer from the energy shortage and oxidative stress. Eventually, the RGCs become so overwhelmed that they trigger a process called apoptosis, or programmed cell death [15][16]. As these cells are lost, the “cable” connecting the eye to the brain thins, leading to the vision changes seen in ADOA.

ADOA vs. LHON: A Key Difference

It is important to distinguish ADOA from Leber’s Hereditary Optic Neuropathy (LHON), another common mitochondrial eye condition.

  • LHON is caused by mutations in the mitochondrial DNA (small loops of DNA inside the mitochondria themselves) and is inherited only from the mother [17][18].
  • ADOA is caused by a mutation in the nuclear DNA (the OPA1 gene) and can be inherited from either parent [19][20].

Understanding that ADOA is a nuclear DNA issue helps doctors determine the best path for genetic counseling and future treatments, such as gene therapies that target the OPA1 gene directly [1][21].

Frequently Asked Questions

What is the role of the OPA1 gene in ADOA?
The OPA1 gene provides instructions for making a protein that keeps your cells' mitochondria healthy and organized. In ADOA, a mutation causes a shortage of this protein, making it hard for cells to produce enough energy.
Why does an OPA1 gene mutation primarily affect my vision?
Vision relies on Retinal Ganglion Cells (RGCs) in your optic nerve, which require massive amounts of constant energy to send visual signals to your brain. When mitochondria fail to produce enough energy, these specific cells become overwhelmed and die off first.
What does haploinsufficiency mean for ADOA patients?
Haploinsufficiency means that because one copy of your OPA1 gene has a mutation, your body only produces about half the normal amount of OPA1 protein. This shortage leads to the cellular energy crisis that causes ADOA symptoms.
What is the difference between ADOA and LHON?
Both are eye conditions related to mitochondria, but they have different genetic causes. ADOA is caused by a mutation in your nuclear DNA that can be inherited from either parent, while LHON is caused by mutations in mitochondrial DNA inherited only from the mother.
Are there lifestyle factors that can make ADOA worse?
Environmental stressors like smoking and exposure to certain toxins can increase oxidative stress on your cells. Eliminating these factors may help reduce the burden on your struggling mitochondria.

Questions for Your Doctor

  • • Does my specific mutation cause haploinsufficiency or a dominant-negative effect, and how does that influence my risk for extraocular symptoms?
  • • Since this is a nuclear DNA mutation (OPA1), what are the specific inheritance risks for my children compared to mitochondrial DNA disorders?
  • • Are there any lifestyle factors beyond smoking that specifically stress the OPA1 protein's ability to maintain mitochondrial fusion?
  • • Is there a way to measure my mitochondrial health or oxidative stress levels as part of my routine checkups?

Questions for You

  • • Have I noticed that I tire more easily during physical activities, which might suggest my 'cellular powerhouses' are struggling?
  • • Am I aware of any environmental factors, like secondhand smoke or specific toxins, that I can eliminate to reduce stress on my mitochondria?
  • • How does understanding the 'energy crisis' in my cells change the way I think about my symptoms and daily energy levels?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Antisense Oligonucleotide STK-002 Increases OPA1 in Retina and Improves Mitochondrial Function in Autosomal Dominant Optic Atrophy Cells.

    Venkatesh A, McKenty T, Ali S, et al.

    Nucleic acid therapeutics 2024; (34(5)):221-233 doi:10.1089/nat.2024.0022.

    PMID: 39264859
  2. 2

    Drosophila model to clarify the pathological significance of OPA1 in autosomal dominant optic atrophy.

    Nitta Y, Osaka J, Maki R, et al.

    eLife 2024; (12()).

    PMID: 39177028
  3. 3

    The short variant of the mitochondrial dynamin OPA1 maintains mitochondrial energetics and cristae structure.

    Lee H, Smith SB, Yoon Y

    The Journal of biological chemistry 2017; (292(17)):7115-7130 doi:10.1074/jbc.M116.762567.

    PMID: 28298442
  4. 4

    Mitochondrial dynamics: overview of molecular mechanisms.

    Tilokani L, Nagashima S, Paupe V, Prudent J

    Essays in biochemistry 2018; (62(3)):341-360 doi:10.1042/EBC20170104.

    PMID: 30030364
  5. 5

    OPA1 regulation of mitochondrial dynamics in skeletal and cardiac muscle.

    Noone J, O'Gorman DJ, Kenny HC

    Trends in endocrinology and metabolism: TEM 2022; (33(10)):710-721 doi:10.1016/j.tem.2022.07.003.

    PMID: 35945104
  6. 6

    Autosomal dominant optic atrophy: A novel treatment for OPA1 splice defects using U1 snRNA adaption.

    Jüschke C, Klopstock T, Catarino CB, et al.

    Molecular therapy. Nucleic acids 2021; (26()):1186-1197 doi:10.1016/j.omtn.2021.10.019.

    PMID: 34853716
  7. 7

    Mitochondrial dysfunction in an Opa1(Q285STOP) mouse model of dominant optic atrophy results from Opa1 haploinsufficiency.

    Kushnareva Y, Seong Y, Andreyev AY, et al.

    Cell death & disease 2016; (7()):e2309 doi:10.1038/cddis.2016.160.

    PMID: 27468686
  8. 8

    p32/C1QBP regulates OMA1-dependent proteolytic processing of OPA1 to maintain mitochondrial connectivity related to mitochondrial dysfunction and apoptosis.

    Noh S, Phorl S, Naskar R, et al.

    Scientific reports 2020; (10(1)):10618 doi:10.1038/s41598-020-67457-w.

    PMID: 32606429
  9. 9

    Targeting DRP1 with Mdivi-1 to correct mitochondrial abnormalities in ADOA+ syndrome.

    Lin Y, Wang D, Li B, et al.

    JCI insight 2024; (9(15)).

    PMID: 38916953
  10. 10

    Disrupted energy metabolism is associated with retinal ganglion cell degeneration in autosomal dominant optic atrophy.

    Kang EY, Tseng YJ, Peng WH, et al.

    Science advances 2026; (12(8)):eadx7815 doi:10.1126/sciadv.adx7815.

    PMID: 41706861
  11. 11

    SARM1 loss protects retinal ganglion cells in a mouse model of autosomal dominant optic atrophy.

    Ding C, Ndiaye PS, Campbell SR, et al.

    The Journal of clinical investigation 2025; (135(12)).

    PMID: 40344041
  12. 12

    Creation of an Isogenic Human iPSC-Based RGC Model of Dominant Optic Atrophy Harboring the Pathogenic Variant c.1861C>T (p.Gln621Ter) in the OPA1 Gene.

    García-López M, Jiménez-Vicente L, González-Jabardo R, et al.

    International journal of molecular sciences 2024; (25(13)) doi:10.3390/ijms25137240.

    PMID: 39000346
  13. 13

    Mitochondrial Gymnastics in Retinal Cells: A Resilience Mechanism Against Oxidative Stress and Neurodegeneration.

    Mirra S, Marfany G

    Advances in experimental medicine and biology 2019; (1185()):513-517 doi:10.1007/978-3-030-27378-1_84.

    PMID: 31884663
  14. 14

    Influence of Opa1 Mutation on Survival and Function of Retinal Ganglion Cells.

    González-Menéndez I, Reinhard K, Tolivia J, et al.

    Investigative ophthalmology & visual science 2015; (56(8)):4835-45 doi:10.1167/iovs.15-16743.

    PMID: 26218912
  15. 15

    A novel ADOA-associated OPA1 mutation alters the mitochondrial function, membrane potential, ROS production and apoptosis.

    Zhang J, Liu X, Liang X, et al.

    Scientific reports 2017; (7(1)):5704 doi:10.1038/s41598-017-05571-y.

    PMID: 28720802
  16. 16

    Contrasting pathophysiological mechanisms of OPA1 mutations in autosomal dominant optic atrophy.

    Yao SQ, Liang JJ, Zhou H, et al.

    Cell death discovery 2025; (11(1)):259 doi:10.1038/s41420-025-02442-8.

    PMID: 40447565
  17. 17

    Mitochondrial optic neuropathies.

    Carelli V, La Morgia C, Yu-Wai-Man P

    Handbook of clinical neurology 2023; (194()):23-42 doi:10.1016/B978-0-12-821751-1.00010-5.

    PMID: 36813316
  18. 18

    Dominant Optic Atrophy and Leber's Hereditary Optic Neuropathy: Update on Clinical Features and Current Therapeutic Approaches.

    Chun BY, Rizzo JF

    Seminars in pediatric neurology 2017; (24(2)):129-134 doi:10.1016/j.spen.2017.06.001.

    PMID: 28941528
  19. 19

    Family Planning in Genetic Optic Atrophies in Israel, a Case Series and a Discussion of Ethical Considerations.

    Rozanes E, Ben-Arzi A, Boas H, et al.

    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2025; (45(2)):153-157 doi:10.1097/WNO.0000000000002232.

    PMID: 39080811
  20. 20

    [Genetic Causes and Genetic Diagnostic Testing of Inherited Optic Atrophies].

    Wissinger B

    Klinische Monatsblatter fur Augenheilkunde 2018; (235(11)):1235-1241 doi:10.1055/a-0759-2094.

    PMID: 30458563
  21. 21

    IT TAKES TWO TO TANGO: potential novel therapies for autosomal dominant optic atrophy.

    Sampige R, Seaborn LEA, Pluenneke M, et al.

    Frontiers in ophthalmology 2025; (5()):1688232 doi:10.3389/fopht.2025.1688232.

    PMID: 41268195

This page explains the biological mechanisms of ADOA for educational purposes only. Always consult your ophthalmologist or genetic counselor to understand how your specific gene mutation affects your health and treatment options.

Stay up to date

Get notified when new research about Autosomal dominant optic atrophy is published.

No spam. Unsubscribe anytime.